In order to establish the functional activity of the adaptive cellular immune system in our cohort of stage IV melanoma patients (Table 1), we first analysed circulating T cells for their expression of the CD3ζ chain and their capacity to secrete IFNγ in response to stimulation with PMA and ionomycin. Here, CD247 is linked to melanoma.